Drug Type siRNA |
Synonyms- |
Action stimulants |
Mechanism MnSOD stimulants(superoxide dismutase 2 stimulants), Transcription factors stimulants(Transcription factors and related regulators stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Injuries, Traumatic | Preclinical | United States | 01 Oct 2025 | |
| Alzheimer Disease | Discovery | United States | 01 Oct 2025 |





